Prostate Cancer - Results from #1440

A real-world experience of pembrolizumab monotherapy in microsatellite instability-high and/or tumor mutation burden-high metastatic castration-resistant prostate cancer: outcome analysis. February 12, 2024

Gender-affirming hormone therapy in transgender women and risk of prostate cancer: pathophysiological mechanisms and clinical implications. February 12, 2024

How can we identify Extraprostatic Extension (EPE) Before Surgery? The Use of a Preoperative Prostate MRI EPE Scoring System to Assess Post-Prostatectomy Locally Advanced Prostate Cancer. February 9, 2024

Repeated Prostate Cancer Screening Using Prostate-Specific Antigen Testing and Magnetic Resonance Imaging: A Secondary Analysis of the STHLM3-MRI Randomized Clinical Trial. February 9, 2024

Incidence of prostate cancer in transgender women in the US: a large database analysis. February 9, 2024

Urinary volatile organic compounds in prostate cancer biopsy pathologic risk stratification using logistic regression and multivariate analysis models. February 9, 2024

Use of rectal balloon spacer in patients with localized prostate cancer receiving external beam radiotherapy. February 9, 2024

Patient-Reported Outcomes 12 Years after Localized Prostate Cancer Treatment. February 8, 2024

Targeted Inhibition of CYP11A1 in Castration-Resistant Prostate Cancer. February 8, 2024

Meta-Analysis of Candidate Surrogate End Points in Advanced Prostate Cancer. February 8, 2024

Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer. February 8, 2024

Association of extended core sampling with delayed intervention and pathologic outcomes for active surveillance patients: A population-based analysis. February 8, 2024

Enzalutamide and Quality of Life in Biochemically Recurrent Prostate Cancer. February 8, 2024

Deep learning-based automated pipeline for blood vessel detection and distribution analysis in multiplexed prostate cancer images. February 8, 2024

Prevention of thromboembolic events after radical prostatectomy in patients with hereditary thrombophilia due to a factor V Leiden mutation by multidisciplinary coagulation management. February 7, 2024

Shared medical decision in prostate cancer screening in primary care: a systematic literature review of current evidence. February 7, 2024

Retzius-sparing vs. posterior urethral suspension: similar early-phase post-robotic radical prostatectomy continence outcomes. February 7, 2024

Dual inhibition of MEK and PI3Kβ/δ-a potential therapeutic strategy in PTEN-wild-type docetaxel-resistant metastatic prostate cancer. February 7, 2024

The complex interplay of modifiable risk factors affecting prostate cancer disparities in African American men. February 7, 2024

First-in-human imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostate. February 6, 2024

Page 73 of 1439